
Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day. As a possible alternative to those injections, MIT researchers are developing an implantable device that contains insulin-producing cells. This device, the researchers hope, could offer a way to achieve long-term control of type 1 diabetes. news.mit.edu/2026/implantab…
English

